Swiss National Bank Dyne Therapeutics, Inc. Transaction History
Swiss National Bank
- $150 Billion
- Q3 2024
A detailed history of Swiss National Bank transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Swiss National Bank holds 105,100 shares of DYN stock, worth $1.49 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
105,100
Previous 105,900
0.76%
Holding current value
$1.49 Million
Previous $3.74 Million
1.02%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding DYN
# of Institutions
207Shares Held
102MCall Options Held
234KPut Options Held
238K-
Atlas Venture Life Science Advisors, LLC8.02MShares$114 Million35.54% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$105 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.86MShares$97.6 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY6.82MShares$97 Million3.9% of portfolio
-
Janus Henderson Group PLC London, X06.81MShares$96.9 Million0.13% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $736M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...